William C. Eckelman
#130,982
Most Influential Person Now
William C. Eckelman's AcademicInfluence.com Rankings
William C. Eckelmanbiology Degrees
Biology
#8635
World Rank
#11742
Historical Rank
Neuroscience
#1208
World Rank
#1252
Historical Rank

Download Badge
Biology
William C. Eckelman's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is William C. Eckelman Influential?
(Suggest an Edit or Addition)William C. Eckelman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. (1997) (1174)
- NCRP report no. 93: Ionizing radiation exposure of the population of the United States: National Council on Radiation Protection and Measurements, Bethesda, Maryland (1987). US$15.00 (1988) (726)
- Reduced Serotonin Type 1A Receptor Binding in Panic Disorder (2004) (356)
- Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. (2009) (269)
- Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. (2006) (264)
- A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer. (2009) (252)
- Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion (1997) (242)
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development (2005) (228)
- PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy (2003) (218)
- First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer (2013) (199)
- Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies (1997) (196)
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer (2013) (190)
- Evaluation of 99mTc-DTPA for the Measurement of Glomerular Filtration Rate (1972) (173)
- Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. (1999) (168)
- Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET (2008) (160)
- Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. (1985) (151)
- External imaging of cerebral muscarinic acetylcholine receptors. (1984) (150)
- New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. (1975) (141)
- Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride. (1983) (132)
- Molecular targets. (2006) (129)
- Receptor-binding radiotracers: a class of potential radiopharmaceuticals. (1979) (123)
- 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. (2005) (121)
- Nuclear medicine : diagnosis and therapy (1996) (120)
- A neutral technetium-99m complex for myocardial imaging. (1989) (120)
- Development of fluorine-18-labeled 5-HT1A antagonists. (1999) (114)
- Unparalleled contribution of technetium-99m to medicine over 5 decades. (2009) (114)
- Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations. (2000) (112)
- Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts. (2000) (104)
- Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. (2006) (101)
- Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. (2004) (98)
- Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. (2004) (97)
- High resolution PET, SPECT and projection imaging in small animals. (2001) (96)
- Muscarinic Cholinergic Receptor Measurements with [18F]FP-TZTP: Control and Competition Studies (1998) (93)
- The labeling of high affinity sites of antibodies with 99mTc. (1985) (86)
- Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907 (2000) (85)
- Instant 99mTc-DTPA. (1970) (85)
- Experiment assessment of mass effects in the rat: implications for small animal PET imaging. (2004) (85)
- Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates. (2013) (84)
- 123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy (2011) (82)
- Fast 18F Labeling of a Near-Infrared Fluorophore Enables Positron Emission Tomography and Optical Imaging of Sentinel Lymph Nodes (2010) (82)
- Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. (2003) (80)
- One-step synthesis of 18F labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. (1994) (80)
- Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats. (1990) (75)
- Radiopharmaceuticals labelled with technetium. (1977) (73)
- A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels (2001) (73)
- No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. (2005) (73)
- Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin. (2006) (71)
- Brain Incorporation of [11C]Arachidonic Acid in Young Healthy Humans Measured with Positron Emission Tomography (2002) (71)
- PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635. (2000) (70)
- The Suitability of [11C]-α-Methyl-L-tryptophan as a Tracer for Serotonin Synthesis: Studies With Dual Administration of [11C] and [14C] Labeled Tracer (2000) (70)
- Cellular Release of [18F]2-Fluoro-2-deoxyglucose as a Function of the Glucose-6-phosphatase Enzyme System* (2000) (68)
- Brain incorporation of [1–11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography (1997) (67)
- L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment. (1996) (66)
- Initial results from a PET/planar small animal imaging system (1998) (66)
- Technetium-labeled red blood cells. (1971) (65)
- Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide. (2010) (65)
- The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography. (2007) (63)
- A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. (2012) (63)
- Evidence for tissue angiotensin-converting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique. (2007) (61)
- In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers (2003) (61)
- S‐[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals (1984) (60)
- Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. (2002) (60)
- Molecular Imaging and Contrast Agent Database (MICAD): Evolution and Progress (2012) (59)
- Distribution of labeled bleomycin in normal and tumor-bearing mice. (1973) (58)
- Optimization of the DTPA mixed-anhydride reaction with antibodies at low concentration. (1983) (57)
- The chemical state of 99m Tc in biomedical products. II. The chelation of reduced technetium with DTPA. (1972) (57)
- The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro. (1984) (54)
- Rhenium tricarbonyl core complexes of thymidine and uridine derivatives. (2005) (54)
- Higher in vivo muscarinic‐2 receptor distribution volumes in aging subjects with an apolipoprotein E‐ϵ4 allele (2003) (54)
- Radiolabeling of antibodies. (1980) (54)
- [I-125] 17α-Iodovinyl 11β-Methoxyestradiol: In Vivo and In Vitro Properties of a High-Affinity Estrogen-Receptor Radiopharmaceutical (1984) (52)
- Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems (1995) (51)
- Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation. (2003) (51)
- The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals. (1994) (50)
- Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection. (1974) (49)
- Preparation of 18F-labeled muscarinic agonist with M2 selectivity. (1995) (49)
- Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography. (1991) (49)
- Brain Uptake of the Acid Metabolites of F-18—Labeled WAY 100635 Analogs (2003) (49)
- Decreased tumor uptake of gallium-67 in animals after whole-body irradiation. (1978) (49)
- Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(4-iodophenyl)-alpha- phenylacetate as potential radiopharmaceuticals. (1984) (49)
- Discussion of targeting proteins in vivo: in vitro guidelines. (2006) (49)
- Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody. (2001) (49)
- Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine. (2008) (48)
- Guidelines to authors submitting papers to the international journal of radiation applications and instrumentation (1991) (48)
- Kinetic Analysis of 3-Quinuclidinyl 4-[125I]Iodobenzilate Transport and Specific Binding to Muscarinic Acetylcholine Receptor in Rat Brain in vivo: Implications for Human Studies (1990) (48)
- Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC). (2009) (47)
- Measurement of Regional Rates of Cerebral Protein Synthesis with L-[1-11C]leucine and PET with Correction for Recycling of Tissue Amino Acids: II. Validation in Rhesus Monkeys (2005) (45)
- Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens. (1986) (45)
- Analytical Pitfalls with 99mTc-labeled Compounds (1972) (44)
- Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111. (1985) (44)
- Receptor-Binding Radiotracers (1982) (44)
- Semi-remote production of [64Cu]CuCl2 and preparation of high specific activity [64Cu]Cu-ATSM for PET studies (2005) (43)
- (Arg15, Arg21) VIP: Evaluation of Biological Activity and Localization to Breast Cancer Tumors (1998) (43)
- The Design of Site-Directed Radiopharmaceuticals for Use in Drug Discovery (1993) (42)
- Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding. (2006) (42)
- Sensitivity of new radiopharmaceuticals. (1998) (41)
- Synthesis, characterization, and in vitro evaluation of nitroimidazole--BATO complexes: new technetium compounds designed for imaging hypoxic tissue. (1993) (41)
- Brain Serotonin Synthesis Rates in Rhesus Monkeys Determined by [11C;[alpha;-Methyl-L-Tryptophan and Positron Emission Tomography Compared to CSF 5-Hydroxyindole-3-Acetic Acid Concentrations (1998) (41)
- Extra-osseous localization of 99Tcm-Sn pyrophosphate. (1975) (40)
- Justifying the number of animals for each experiment. (2007) (40)
- The single-pass cerebral extraction and capillary permeability-surface area product of several putative cerebral blood flow imaging agents. (1993) (40)
- Vascular-Targeted Radioimmunotherapy with the Alpha-Particle Emitter 211At (2002) (39)
- Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography (2007) (39)
- [125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors. (1984) (39)
- Targeting proteins in vivo: in vitro guidelines. (2006) (39)
- Analogues of 3-quinuclidinyl benzilate. (1982) (37)
- Role of radionuclide imaging in trials of antiangiogenic therapy. (2000) (37)
- Chemical and biologic properties of isolated radiolabeled bleomycin preparations. (1975) (37)
- Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets. (1998) (37)
- THE DISTRIBUTION OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS, QUINUCLIDINYL BENZILATE AND QUINUCLIDINYL BENZILATE METHIODIDE (BOTH TRITIATED), IN RAT, GUINEA PIG, AND RABBIT (1979) (36)
- Chemical state of 99mTc in biomedical products. (1971) (36)
- The use of PET and knockout mice in the drug discovery process. (2003) (36)
- Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia. (2013) (36)
- Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice (2003) (36)
- Incorporation of [1-carbon-11]palmitate in monkey brain using PET. (1995) (36)
- Labeling proteins at high specific activity using N-succinimidyl 4-[18F](fluoromethyl) benzoate. (1997) (35)
- Synthesis and evaluation of (17 alpha,20E)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17 -diol and (17 alpha,20E)-21-[125I]iodo-11 beta-methoxy-19-norpregna-1,3,5(10),20-tetraene-3,17-diol (17 alpha-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceuticals. (1984) (35)
- Differential effects of paroxetine on raphe and cortical 5-HT1A binding: A PET study in monkeys (2005) (34)
- Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment. (1997) (34)
- Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression (2008) (34)
- Fluoro analogs of WAY-100635 with varying pharmacokinetics properties. (2000) (34)
- Imaging of muscarinic receptors in the central nervous system. (2006) (33)
- True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123? (2008) (33)
- Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems! (2009) (33)
- Amphetamine-Induced Dopamine Release (2001) (33)
- Comparative Chemical Structure and Pharmacokinetics of MRI Contrast Agents (1988) (33)
- Synthesis, plasma clearance, and in vitro stability of protein containing a conjugated indium-111 chelate (1980) (33)
- Biologically stable [(18)F]-labeled benzylfluoride derivatives. (2000) (33)
- Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin (2004) (33)
- Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer. (1985) (33)
- CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. (2002) (32)
- VIP and Breast Cancer (1998) (32)
- Autoradiographic visualization of corticotropin releasing hormone type 1 receptors with a nonpeptide ligand: synthesis of [(76)Br]MJL-1-109-2. (2003) (32)
- Small molecule inhibitors of PSMA incorporating technetium-99m for imaging prostate cancer: Effects of chelate design on pharmacokinetics (2012) (32)
- Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac. (2001) (32)
- Semi-automated 86Y purification using a three-column system. (2004) (31)
- Radioiodinated estrogen derivatives. (1980) (31)
- Accelerating drug discovery and development through in vivo imaging. (2002) (30)
- Evaluation of 99mTc-DTPA prepared by three different methods. (1971) (30)
- Comparative chemical structure and pharmacokinetics of MRI contrast agents. (1988) (30)
- Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC. (1991) (30)
- Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression (2013) (30)
- Three approaches to radiolabeling antibodies with 99mTc. (1989) (29)
- 99mTc-pyrophosphate for bone imaging. (1974) (29)
- Labeling monoclonal antibodies and F(ab')2 fragments with (111In) indium using cyclic DTPA anhydride and their in vivo behavior in mice bearing human tumor xenografts. (1984) (29)
- Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors. (1983) (29)
- 99 mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer (2013) (29)
- In vivo competition studies with analogues of 3-quinuclidinyl benzilate. (1984) (28)
- Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635. (2006) (28)
- Biological distribution of chemical analogs of fatty acids and long chain hydrocarbons containing a strong chelating agent. (1977) (27)
- Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes. (2001) (27)
- Early imaging in heart failure: Exploring novel molecular targets (2007) (27)
- A Potential Cholinergic Mechanism of Procaine's Limbic Activation* (2004) (26)
- Analysis of residual solvents in 2-[(18)F]FDG by GC. (2001) (26)
- In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model. (1993) (26)
- Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate. (1975) (25)
- Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilates. (1995) (25)
- Determination of [18F]FCWAY, [18F]FP-TZTP, and their metabolites in plasma using rapid and efficient liquid-liquid and solid phase extractions. (2003) (25)
- In Vitro and In Vivo Characteristics (1989) (25)
- Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression (2013) (25)
- Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist. (1985) (25)
- Radioassays and experimental evaluation of dose calibrator settings for 18F. (2001) (25)
- Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele. (2003) (24)
- Synthesis of 4-[18F]fluorobenzoyllisinopril: A radioligand for angiotensin converting enzyme (ACE) imaging with positron emission tomography (2001) (24)
- Evaluation of 99m Tc-DTPA for the measurement of glomerular filtration rate. (1972) (24)
- [77Br]-17-alpha-Bromoethynylestradiol: in vivo and in vitro characterization of an estrogen receptor radiotracer. (1982) (24)
- A handbook of radioactivity measurements procedures: National Council on Radiation Protection and Measurements. NCRP Report No. 58, 2nd edn (1985). NCRP Publications, 7910 Woodmont Avenue, Bethesda, MD 20814, U.S.A. US $22 (1985) (23)
- A neutral lipophilic technetium-99m complex for regional cerebral blood flow imaging. (1990) (23)
- Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: the development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor. (2000) (23)
- In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilate. (1989) (23)
- Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites. (2013) (23)
- Reactions of recoiling silicon atoms with phosphine, silane, and ethylene (1968) (22)
- The chemistry of technetium labeling of radiopharmaceuticals by electrolysis. (1974) (22)
- [125I]17-α-Iodovinyl 11-β-Methoxyestradiol Interaction in Vivo with Estrogen Receptors in Hormone-independent MCF-7 Human Breast Cancer Transfected with the v-rasH Oncogene (1987) (22)
- Estrogen derivatives for the external localization of estrogen-dependent malignancy. (1977) (22)
- Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human glioma. (2005) (21)
- Visualization of the human spleen with 99mTc-labeled red blood cells. (1971) (21)
- Binding Characteristics and Biological Activity of 17α-[125I]Iodovinyl-11β-methoxyestradiol, an Estrogen Receptor-binding Radiopharmaceutical, in Human Breast Cancer Cells (MCF-7) (1986) (21)
- The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions. (1998) (21)
- Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization. (1976) (21)
- The classification of radiotracers. (1978) (20)
- Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence. (1999) (20)
- The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure (2007) (20)
- Theory and Practice of Imaging Saturable Binding Sites (2002) (20)
- Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment. (1997) (20)
- Transchelation of 99mTc from low affinity sites to high affinity sites of antibody. (1986) (19)
- Comparison of an 18F labeled derivative of vasoactive intestinal peptide and 2-deoxy-2-[18F]fluoro-D-glucose in nude mice bearing breast cancer xenografts. (2002) (19)
- Radioiodinated Derivatives of β Adrenoceptor Blockers for Myocardial Imaging (1978) (19)
- Quantification of Kryptofix 2.2.2 in 2-[(18)F]FDG and other radiopharmaceuticals by LC/MS/MS. (2002) (19)
- Identification of metabolites of fluorine-18-labeled M2 muscarinic receptor agonist, 3-(3-[(3-fluoropropyl)thio]-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine, produced by human and rat hepatocytes. (2002) (19)
- Technetium labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2. (1991) (18)
- Technical considerations in labeling of blood elements. (1975) (18)
- Quantitative analysis of tumor biochemisty using PET and SPECT. (2000) (18)
- Important parameters to consider for the characterization of PET and SPECT imaging probes. (2011) (18)
- Preparation and in vivo evaluation of novel linkers for 211At labeling of proteins. (2004) (18)
- Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv. (1998) (18)
- Vascular imaging with 99m Tc-red blood cells. (1973) (18)
- Distribution of the 5-HT1A receptor antagonist [18F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia (2007) (18)
- The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type. (2001) (17)
- In vivo chemistry of 99mTc-chelates. (1982) (17)
- In vivo receptor binding of iodinated beta-adrenoceptor blockers. (1980) (17)
- Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteins. (1997) (17)
- Evaluation of human transferrin radiolabeled with N-succinimidyl 4-[fluorine-18](fluoromethyl) benzoate. (1996) (17)
- Application of LC-MS to the analysis of new radiopharmaceuticals. (2003) (17)
- Calculation of binding isotherms when ligand and receptor are in different volumes of distribution. (1980) (17)
- Evaluation of [76Br]FBAU 3',5'-dibenzoate as a lipophilic prodrug for brain imaging. (2002) (16)
- [68Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [68Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence (2019) (16)
- Characterization of nanoparticle-based contrast agents for molecular magnetic resonance imaging (2012) (16)
- The Synthesis and In Vivo Pharmacokinetics of Fluorinated Arachidonic Acid: Implications for Imaging Neuroinflammation (2012) (16)
- Reversed-phase high-performance liquid chromatography of bleomycin. (1976) (16)
- Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At. (2004) (16)
- Direct labeling with 99mTc. (1991) (16)
- In vivo muscarinic binding selectivity of (R,S)- and (R,R)-[18F]-fluoromethyl QNB. (1997) (15)
- Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic? (2005) (15)
- Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution (2007) (15)
- True tracer radiolabeling of gadolinium complex of 10‐(2‐hydroxypropyl)‐1,4,7,10‐tetraazacyclododecane‐1,4,7 triacetic acid (HP‐DO3A) (1993) (15)
- The use of gene-manipulated mice in the validation of receptor binding radiotracer. (2003) (15)
- Semi-remote production of Br-76 and preparation of high specific activity radiobrominated pharmaceuticals for PET studies (2004) (14)
- Biomedical imaging research opportunities workshop IV: a white paper. (2007) (14)
- Automated synthesis of 6-[18F]fluoro-l-DOPA using modified polystyrene supports with bound 6-mercuric DOPA precursors (1998) (14)
- Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands. (1999) (14)
- Synthesis and evaluation of an 18F analog of forskolin for imaging adenylyl cyclase (2000) (14)
- [131I]MIP-1466, a small molecule prostate-specific membrane antigen (PSMA) inhibitor for targeted radiotherapy of prostate cancer (PCa) (2012) (14)
- Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC). (2007) (14)
- Molecular nuclear medicine. The challenge of genomic and proteomics to clinical practice (2003) (13)
- A Radioimmunoassay for SQ 27,519, the Active Phosphinic Acid‐Carboxylic Diacid of the Prodrug Fosinopril in Human Serum (1990) (13)
- Kinetic Analysis of 3-Quinuclidinyl 4-[125] Iodobenzilate Transport and Specific Binding to Muscarinic Acetylcholine Receptor in Rat Brain In Vivo (1989) (13)
- Animal Models in Radiotracer Design (2011) (13)
- Radiolabeled muscarinic radioligands for in vivo studies. (2001) (13)
- Device-dependent activity estimation and decay correction of radionuclide mixtures with application to Tc-94m PET studies. (2001) (13)
- Receptor 1980 and Receptor 2000: twenty years of progress in receptor-binding radiotracers. (2001) (13)
- Liquid chromatography-tandem mass spectrometry identification of metabolites of three phenylcarboxyl derivatives of the 5-HT(1A) antagonist, N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridyl) trans-4-fluorocyclohexanecarboxamide (FCWAY), produced by human and rat hepatocytes. (2002) (13)
- National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
- Species differences in metabolites of PET ligands: serotonergic 5-HT1A receptor antagonists 3-trans-FCWAY and 3-cis-FCWAY. (2006) (12)
- [76Br]BMK‐I‐152, a non‐peptide analogue for PET imaging of corticotropin‐releasing hormone type 1 receptor (CRHR1) (2009) (12)
- NEW COMPOUNDS, FATTY ACID AND LONG-CHAIN HYDROCARBON DERIVATIVES CONTAINING A STRONG CHELATING AGENT (1975) (12)
- Development of radiochemically pure antibodies. (1990) (12)
- 99m Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer (2013) (12)
- Monitoring the correction of glycogen storage disease type 1a in a mouse model using [(18)F]FDG and a dedicated animal scanner. (2002) (12)
- Molecular Nuclear Medicine (2003) (11)
- Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain. (1995) (11)
- Splenic sequestration of 99m Tc-labeled red blood cells. (1972) (11)
- The use of in vitro models to predict the distribution of receptor binding radiotracers in vivo. (1989) (11)
- Reaction of Recoiling Silicon Atoms with Phosphine and Silane (1966) (11)
- High-specific-activity 99m Tc Human serum albumin. (1972) (11)
- Development of a simple kit for Tc-99m-MIP-1404, a single amino acid chelate (SAAC II) derived small molecule inhibitor of prostate specific membrane antigen (PSMA) for imaging prostate cancer (2012) (11)
- A rapid simple improved method for the preparation of Tc99m red blood cells for the determination of red cell volume. (1973) (11)
- Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: a potent radioligand for corticotropin-releasing hormone type 1 receptor (2000) (11)
- Radiochemical Purity of New Radiopharmaceuticals (1976) (10)
- Reactions of recoiling silicon atoms with phosphine and butadiene, and the addition of silylene to butadiene (1974) (10)
- Measurement of transferrin receptor kinetics in the baboon liver using dynamic positron emission tomography imaging and [18F]holo‐transferrin (1997) (10)
- Comparison of 99mTc and 111In labeling of conjugated antibodies. (1986) (10)
- Use of 1,8‐bis‐(dimethylamino)‐naphthalene/H18F complex as new radiofluorinating agent (2004) (10)
- The status of radiopharmaceutical research. (1991) (10)
- Radiochemical synthesis and biodistribution of a novel maxi-K potassium channel opener. (2002) (10)
- The toxicity of Sn-pyrophosphate: clinical manifestations prior to acute LD50. (1974) (10)
- Inhibition of [18F]FP‐TZTP binding by loading doses of muscarinic agonists P‐TZTP or FP‐TZTP in vivo is not due to agonist‐induced reduction in cerebral blood flow (2003) (10)
- Perspective, the one most responsive to change. (2014) (10)
- Imaging the renin-angiotensin-aldosterone system in the heart (2005) (10)
- Why does the agonist [18F]FP-TZTP bind preferentially to the M2 muscarinic receptor? (2006) (10)
- Synthesis of polymer-bound 6-mercuric carboxylate DOPA precursors and solid phase labelling method of 6-radioiodinated L-DOPA. (1996) (9)
- Radiochemical synthesis of [18F]fluoropaclitaxel ([18F]FPAC) (2001) (9)
- Molecular imaging and contrast agent database (MICAD): A component of the NIH Roadmap (2006) (9)
- Utility of azetidinium methanesulfonates for radiosynthesis of 3‐[18F]fluoropropyl amines (2004) (9)
- Chemistry and Biology of Radiotracers That Target Changes in Sympathetic and Parasympathetic Nervous Systems in Heart Disease (2015) (9)
- No‐carrier‐added bromination of estrogens with chloramine‐t and Na77Br (1981) (9)
- Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay. (1979) (9)
- The sequential syntheses of [76Br]FBAU 3′,5′‐dibenzoate and [76Br]FBAU (2001) (9)
- Essential parameters to consider for the characterization of optical imaging probes. (2012) (9)
- Myocardial Blood Flow and Innervation Measures from a Single Scan: An Appealing Concept but a Challenging Paradigm (2015) (8)
- NMR ENHANCEMENT WITH Gd LABELED ANTIBODIES (1988) (8)
- Review of new clinical applications of radiometal labeled radiopharmaceuticals. (2011) (8)
- Cardioselectivity of beta-adrenoceptor blocking agents. 2. Role of the amino group substituent. (1983) (8)
- An automated radiopharmaceutical dispenser. (1997) (8)
- Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: syntheses and studies of their binding to the muscarinic acetylcholine receptor. (1995) (8)
- The use of tritium labeled compounds to develop gamma-emitting receptor-binding radiotracers. (1982) (8)
- Scatchard Analysis with Bolus/Infusion Administration of [11C]Raclopride (2002) (8)
- Technetium-99m-pyridoxylideneglutamate, a new agent for gallbladder imaging: comparison with 131I-rose bengal. (1976) (8)
- Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype. (1996) (8)
- Further discussions on choosing the number of animals for an experiment. (2008) (8)
- Instant 99mTc Compounds (1971) (7)
- Routine quality control of recycled target [18O]water by capillary electrophoresis and gas chromatography. (2003) (7)
- Three radioligands compared for determining cytoplasmic estrogen-receptor content of human breast carcinomas. (1982) (7)
- Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP. (2012) (7)
- Mechanism of Target Specific Uptake Using Examples of Muscarinic Receptor Binding Radiotracers (2005) (7)
- A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent. (1993) (7)
- Technetium-99m special issue (1982) (7)
- An automated one-step one-pot [(18)F]FCWAY synthesis: development and minimization of chemical impurities. (2007) (7)
- The Potential Uses of Radiopharmaceuticals in the Pharmaceutical Industry (1993) (7)
- Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. (2008) (7)
- Rational development of radiopharmaceuticals for HIV-1. (2014) (6)
- Technetium labeling of albumin. (1972) (6)
- Thyroidal pertechnetate uptake in Hashimoto's disease. (1971) (6)
- In vivo and in vitro characteristics of the N-methyl derivative of [125I]3-quinuclidinyl 4-iodobenzilate. (1984) (6)
- Synthesis of polymer-bound 6-thiolatomercury and 6-mercuric sulfonate DOPA precursors and their halodemercuration reactivity. (1995) (6)
- Trend Analysis of Quality Control Data (1995) (6)
- Synthesis and screening of conformationally restricted and conformationally free N-(tertiary aminoalkyl)dithiocarbamic acids and esters as inhibitors of neuronal nitric oxide synthase. (1998) (6)
- Kinetic analysis of muscarinic receptors in human brain and salivary gland in vivo. (1995) (6)
- Electrophilic iodination of aromatic rings. (1984) (6)
- Choosing a target for targeted radionuclide therapy using biomarkers to personalize treatment (2014) (6)
- Novel imaging strategies for predicting remodeling and evolution of heart failure: targeting the Renin-Angiotensin system. (2006) (6)
- SYNTHESIS AND EVALUATION OF RADIOIODINATED DERIVATIVES OF 1‐AZABICYCLO(2.2.2)OCT‐3‐YL α‐HYDROXY‐α‐(4‐IODOPHENYL)‐α‐PHENYLACETATE AS POTENTIAL RADIOPHARMACEUTICALS (1984) (6)
- 99m Tc-DTPA preparations. (1971) (5)
- Receptor-selective localization in pancreas. (1985) (5)
- Nonpeptide corticotropin releasing hormone type 1 receptor antagonists as medications and imaging agents (2002) (5)
- Evidence for increased angiotensin II type 1 receptor immunoreactivity in peri-infarct myocardium of human explanted hearts (2002) (5)
- The Use of Positron Emission Tomography in Drug Discovery and Development (2005) (5)
- Interaction of iodinated quinuclidinyl benzilate enantiomers with M3 muscarinic receptors. (1994) (5)
- What is to be gained by imaging the same animal before and after treatment? (2005) (5)
- Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols. (1979) (5)
- Analytical pitfalls with 99m Tc-labeled compounds. (1972) (5)
- Choosing a single target as a biomarker or therapeutic using radioactive probes. (2015) (5)
- Evaluation of [18F]fluoroxanomeline {5-{4-[(6-[18F]fluorohexyl)oxy]-1,2,5-thiadiazol-3-yl}-1-methyl-1,2,3,6-tetrahydropyridine} in muscarinic knockout mice. (2007) (5)
- Designing a molecular probe for muscarinic acetylcholine receptor (mAChR) imaging. (1995) (4)
- Synthesis and evaluation of radioligands for angiotensin converting enzyme (ACE) imaging (2006) (4)
- Pharmacokinetics of 99MTC-myocardial perfusion agents in different species (1989) (4)
- Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006. (2007) (4)
- Synthesis and evaluation of radioiodinated 6-iodo-L-DOPA as a cerebral L-amino acid transport marker. (1996) (4)
- Re: Receptor binding of F-18 haloperidol and spiroperidol. (1984) (4)
- [I-125] 17 alpha-Iodovinyl 11 beta-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical. (1984) (4)
- Mülhardt: Molecular biology and genomics Translated by E.W. Beese, M.D., 2006, Paperback, 300 pp. 0-12-088546-8. Academic Press. An imprint of Elsevier (2007) (4)
- Purification of the precursor for the automated radiosynthesis of [18F]FCWAY by counter-current chromatography. (2004) (4)
- Nuclear Imaging and Biomarkers in Drug Development Using Approved Radiopharmaceuticals (2001) (4)
- Labeled Agents as Tracers and Carriers: Theory and Practice (2003) (3)
- Scintigraphic and immunohistochemical evidence for localization of angiotensin converting enzyme to myocytes in human ischemic cardiomyopathy (2003) (3)
- [11C]diazepam synthesis : N-[11C]methylation of desmethyldiazepam is facilitated by utilization of a preformed sodium salt/benzo-15-crown-5 complex (1999) (3)
- Receptors labeled with gamma-emitting radiotracers. (1986) (3)
- Proceedings: use of imaging in drug R&D (1999) (3)
- Targeted molecular imaging: target significance and probe validation. (2012) (3)
- The Chemical and Biological Properties of Isolated Radiolabeled Bleomycin Components (1975) (3)
- The development of single-photon emitting receptor-binding radiotracers (1992) (3)
- Evaluation of 99mTc-Pyridoxylideneglutamate for the Differential Diagnosis of Jaundice (1976) (3)
- European Association of Nuclear Medicine Congress (2004) (3)
- Tc-99m labeled red blod cells: a new radiopharmaceutical for the determination of total blood volume and blood pool scanning. (1973) (3)
- Technetium-labeled red blood cells. (1971) (3)
- A review of new oncotropic tracers for PET imaging. (1996) (3)
- Animal Models in Biomedical Research and Radiotracer Design (1983) (3)
- THE DEVELOPMENT OF MUSCARINE CHOLINERGIC RECEPTOR-BINDING RADIOTRACERS (1982) (2)
- Molecular imaging and contrast agent database (MICAD): Progress and current status (2010) (2)
- Principles of molecular targeting for radionuclide therapy (2017) (2)
- From bench to bedside. (2003) (2)
- Changes: choosing a target? (2011) (2)
- SQ 32097: A potential TC-99M labeled brain imaging agent (1989) (2)
- Exchange labeling of proteins:99mTc labeled transferrin (1980) (2)
- Cyclotron production and potential clinical application of Iodine-124 labeled radiotracers (2001) (2)
- 89. A potential cholinergic mechanism of procaine's limbic activation (1998) (2)
- Synthesis of doubly 13C-labelled antalarmin isotopomers for pharmacokinetic studies (2002) (2)
- One of three thousand. (1981) (2)
- Radiopharmaceutical space. (2006) (2)
- Theoretical Analysis of Optimal Conditions in Fquilibrium Imaging of in Vivo Receptors (1985) (2)
- Direct analysis of whole blood by internal surface reversed-phase chromatography: an examination of the binding and metabolism of technetium dioxime complexes. (1992) (2)
- The Design of Receptor-Binding Radiotracers (2019) (2)
- Targeting Prostate Cancer with Small Molecule Inhibitors of Prostate-Specic Membrane Antigen (2012) (1)
- Receptors in Hormone-independent MCF-7 Human Breast Cancer Transfected with the \-rasH Oncogene (1987) (1)
- 18F-labeled small molecule inhibitors of prostate specific membrane antigen (PSMA) for PET imaging of prostate cancer (2012) (1)
- Letter: Chemical state of technetium in vivo. (1976) (1)
- Nuclear Medicine Imaging (1984) (1)
- Chemical State of Technetium In vivo (Letter No. 1) (1976) (1)
- Alteration of 99mTc Red Blood Cells—Authors' Reply (1972) (1)
- Preface for "The quantification with FDG as seen by a physician" by Galli et al. (2013) (1)
- ANALOGS OF 3-QUINUCLIDINYL BENZILATE (1983) (1)
- Muscarinic cholinergic2 receptor binding in bipolar disorder: Relation to saliency of affective-words (2005) (1)
- JOURNAL OF DIAGNOSTIC IMAGING IN THERAPY (2014) (1)
- Evaluation of 99mTc-labeled small molecule inhibitors of carbonic anhydrase (CA) for imaging hypoxia (2012) (1)
- Introduction: Diagnostic imaging in oncology, 28–30 April 1993, Naples, Italy (1994) (1)
- Analogues of estradiol as potential breast tumor imaging agents (1984) (1)
- Radiopharmaceutical quality assurance--pilot study. (1981) (1)
- Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins: m2 antagonist binding to the muscarinic m2 subtype receptor. (1997) (1)
- Preparation of a stable /sup 99m/Tc complex of F(ab')/sub 2/-DTPA and its biodistribution in mice (1984) (1)
- Process for preparing iodovinyl-estradiol (1986) (1)
- Diagnostic isotopes. Prospects for improved agents. (1989) (1)
- Alun G. Jones PhD, 1941–2012 (2013) (1)
- The past, present, and the promise of the future of nuclear medicine and biology. (2017) (1)
- Recent Advances in Radiopharmaceuticals (1992) (1)
- CARDIOSELECTIVITY OF β-ADRENOCEPTOR BLOCKING AGENTS. 2. ROLE OF THE AMINO GROUP SUBSTITUENT (1983) (1)
- Radiolabeling of unprotected octreotide with F-18 (2001) (1)
- Imaging neuroinflammation in Alzheimer disease with [1–11C] arachidonic acid and positron emission tomography (2005) (1)
- Reply to: The Validity of the PET/α-[11C]Methy-L-Tryptophan Method for Measuring Rates of Serotonin Synthesis in Human Brain (1999) (1)
- After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome. (2007) (1)
- Erratum to “What is to be gained by imagine the same animal before and after treatment?” [Nucl Med Biol 2005;32:727–32] (2006) (1)
- Small molecule carbonic anhydrase IX inhibitors for targeted molecular imaging of cancer by SPECT (2009) (1)
- The feasibility of recycling glass liquid scintillation vials. (1982) (1)
- [α-11C]Methyl-l-tryptophan in Anesthetized Rhesus Monkeys (2001) (1)
- Comparison of myocardial uptake and distribution of thallium-201 and two prototype receptor-binding radiopharmaceuticals in the normal and ischemic canine heart. (1984) (1)
- [125I]17-alpha-iodovinyl 11-beta-methoxyestradiol interaction in vivo with estrogen receptors in hormone-independent MCF-7 human breast cancer transfected with the v-rasH oncogene. (1987) (1)
- Oncologic Drug Development The Progress and Promise of Molecular Imaging Probes in (2005) (1)
- Molecular Imaging and Contrast Agent Database (MICAD): Progress and accomplishments (2007) (1)
- PET imaging of dopamine receptors in MPTP-induced parkinsonism (1984) (1)
- Chemistry and Biology of Radiotracers Designed to Target Changes in the Myocardial Sympathetic and Parasympathetic Nervous Systems as a Function of Disease or Treatment (2017) (1)
- Instant 99m compounds. (1971) (1)
- /sup 99m/Tc-pyrophosphate for bone imaging (1974) (1)
- Does Labeled |[agr]|-Methyl-L-Tryptophan Image ONLY Blood|[ndash]|Brain Barrier Transport of Tryptophan? (Reply) (2000) (1)
- “Second-generation single-amino-acid chelate technology with enhanced hydrophilicity: development and successful application to molecular imaging” (2010) (0)
- The development of drugs for low capacity sites by noninvasive imaging (1992) (0)
- Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). (1986) (0)
- In vitro and in vivo quality control: Differences in metabolites of radiotracers produced by rat, monkey, and human hepatocytes, invited (2004) (0)
- Gadolinium labeled antibodies for use in magnetic resonance imaging (MRI) (1986) (0)
- Comparison of SSTR2 agonist and antagonist peptides incorporating a novel 99mTc-chelator for targeting neuroendocrine tumors (2011) (0)
- Applications of Nuclear Imaging in Drug Discovery and Development (2006) (0)
- NIH MICAD and new program initiatives (2008) (0)
- Introduction (1999) (0)
- Labeling of blood cells with /sup 99m/Tc (1974) (0)
- Metabolites of three phenylcarboxyl derivatives of the 5‐HT1A antagonists, way 100635, produced by human and rat hepatocytes (2001) (0)
- Characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro. [Rats] (1984) (0)
- Radioiodinated derivatives of beta adrenoceptor blockers for myocardial imaging. (1978) (0)
- Receptor—Binding Radiotracers: A Class of Potential Radiopharmaceuticais (2006) (0)
- Nuclear medicine pioneer Paul Harper, 1915–2005 (2006) (0)
- Synthesis and Biological Activity of Fluoro‐Substituted Pyrrolo[2,3‐d]pyrimidines. The Development of Potential Positron Emission Tomography Imaging Agents for the Corticotropin‐Releasing Hormone Type 1 Receptor. (2000) (0)
- Important Chemical Variables for Labeling Antibodies with Indium-111 and Technetium-99m (1988) (0)
- Synthesis of [76Br] 1-(2-fluoro-2-deoxy-3,5-O-dibenzoyl-β-D-arabinofuranosyl)-5-BRO mouracil([76Br]FBAU 3′,5′-dibenzoate) and its evaluation as a tracer for imaging brain cell proliferation (2001) (0)
- Radiotracer Localization by Receptor-Ligand Interactions (2021) (0)
- Influence of functionalized chelators on affinity and pharmacokinetics of 99mTc(CO)3-labeled small molecules targeting prostate specific membrane antigen (PSMA) (2010) (0)
- 99mTc-Labeled carbonic anhydrase IX (CA IX) inhibitors for molecular imaging of cancer (2010) (0)
- Molecular targeting using advanced single amino acid chelates (SAAC) for 99mTc (2009) (0)
- Future Development of Radiopharmaceuticals (1992) (0)
- THE TOXICITY OF Sn-PYROPHOSPHATE: (2006) (0)
- Positron emission tomography: radiochemistry. (1995) (0)
- CARDIOSELECTIVITY OF β-ADRENOCEPTOR BLOCKING AGENTS. 1. 1-((4-HYDROXYPHENETHYL)AMINO)-3-(ARYLOXY)PROPAN-2-OLS (1979) (0)
- Target Significance and Probe Validation * (2012) (0)
- Synthesis and evaluation of a series of M(CO)3+ [M=Tc,Re] lisinopril complexes for imaging angiotensin converting enzyme (ACE) (2007) (0)
- Preface: New Trends in Nuclear Oncology 27–29 September 1995, Naples, Italy (1996) (0)
- Potential for imaging ovarian carcinoma by radioiodinated 11. beta. methoxy 17. cap alpha. -iodovinylestradiol (MIVE/sub 2/) (1984) (0)
- 99mTc-MIP-1340, a small molecule inhibitor of PSMA for molecular imaging of prostate cancer (2010) (0)
- Henry N. Wagner, Jr MD (2013) (0)
- Molecular imaging for monitoring prostate cancer response to paclitaxel (2010) (0)
- Conference Report: 2005 MIRT Workshop (2005) (0)
- Subtype selective muscarinic ligands for receptor imaging (1995) (0)
- /sup 99m/Tc--DTPA RENAL STUDY. (1972) (0)
- 368. Muscarinic 2 receptors in cognitively normal young and old volunteers (2000) (0)
- Authors' Reply (2000) (0)
- The development of additional radioligands of varying pharmacokinetics for the 5‐HT1A receptor (2001) (0)
- Altered distribution of (R)-quinuclidinyl I-125 4-iodobenzilate after whole body fission neutron or cobalt-60 irradiation (1984) (0)
- Evaluation of 99mTc-MIP-1407, an octreotide analog for targeting neuroendocrine tumors (2010) (0)
- The production of F-18 on low flux reactors (1985) (0)
- A name change for the Society: perspectives. (2011) (0)
- Biodistribution and pet imaging of muscarinic subtype selective 3-(3-(3-fluoropropylthio)-1,2,5-thiadiazol-4-yl)-tetrahydro-1-methyl-pyridine (FP-TZTP) and R 3-quinuclidinyl S-fluoromethyl benzilate (FMeQNB) (1997) (0)
- Synthesis and Evaluation of an 18F Analogue of Forskolin for Imaging Adenylyl Cyclase. (2000) (0)
- Agglutination of labeled RBC. (1972) (0)
- A Muscarinic Receptor Ligand: Review of the Chemistry and Applications (1991) (0)
- Comparison of tc-99m and in-111 labeling of DTPA conjugated antibodies (1986) (0)
- Receptor Binding Radiotracers: Volume II (2017) (0)
- Receptor Binding Radiotracers (1982) : Volume II (2017) (0)
- In vivo muscarinic binding selectivity of QNB (1997) (0)
- Preparation of receptor binding radiotracers (1979) (0)
- Toxicity of Sn-pyrophosphate: clinical manifestations prior to acute LD$sub 50$ (1974) (0)
- The development of an SAR with small molecule inhibitors of prostate specific membrane antigen (PSMA) (2008) (0)
- EVALUATION OF 99mTc-DTPA FOR THE Determination of glomerular filtration rate offers one of the best ways to evaluate renal function, espe cially the rate of progression of chronic renal dis (2006) (0)
- Translational Applications of Molecular Imaging and Radionuclide Therapy (2005) (0)
- SYNTHESIS AND EVALUATION OF (17α,20E)-21-(125I)IODO-19-NORPREGNA-1,3,5(10),20-TETRAENE-3,17-DIOL AND (17α,20E)-21-(125I)IODO-11β-METHOXY-19-NORPREGNA-1,3,5(10),20-TETRAE# NE-3,17-DIOL (17α-IODOVINYL)ESTRADIOL DERIVATIVES) AS HIGH SPEC (1985) (0)
- Evaluation of ( 18 F)fluoroxanomeline {5-{4-((6-( 18 F)fluorohexyl)oxy) (2007) (0)
- SPLENIC SEQUESTRATION OF 99mTCLABELED RED BLOOD CELLS (1972) (0)
- Technetium-99m Pyrophosphate for Bone Imaging. (1974) (0)
- In vivo estimates of synaptic dopamine concentrations with 11C-raclopride/pet: A direct test of the dopamine hypothesis (1995) (0)
- Synthesis and SAR of novel 99mTc/Re(CO)3 labeled benzenesulfonamide (BzSA) conjugates targeting carbonic anhydrase IX (CA IX) (2012) (0)
- Studies with I-125-MIVE/sub 2/ in human breast cancer cells (MCF-7) (1985) (0)
- Targeted Optical Molecular Imaging with Cytate: From Bench toward Bedside (2012) (0)
- Preclinical evaluation of a series of 99mTc-labeled carbonic anhydrase IX (CA IX) inhibitors for the detection of solid tumors (2012) (0)
- Contrast media and radiopharmaceutical agents: regulatory issues. (1995) (0)
- The Testing of Putative Receptor Binding Radiotracers in vivo (2021) (0)
- Targeted Radiopharmaceuticals: Advances in Radiopharmacology and Radiopharmacy (2012) (0)
- Radioimpurity profile of Tc-99m-MIP-1404, a single amino acid chelate derived inhibitor of prostate specific membrane antigen (PSMA) for imaging prostate cancer (2012) (0)
- TH-E-330D-01: BIROW - Biomedical Imaging Research Opportunities Workshop: Intersociety Project to Accelerate Biomedical Imaging Discovery and Application - Part II (2006) (0)
- Radiolabeling of Antibodies 1 (2006) (0)
- Design and evaluation of novel glutamate-urea heterodimers that target PSMA as molecular imaging agents for prostate cancer. (2007) (0)
- Radiolabeled Adrenergic and Muscarinic Blockers for in Vivo Studies (2019) (0)
- Targeted Molecular Imaging in Cardiology (2007) (0)
- In vivo chemistry of technetium chelates (1981) (0)
- Technetium-99m Pyrophosphate: Comparison of ED50 for Tetany and Acidosis with Acute LD500 (1974) (0)
- Molecular imaging of tumor carbonic anhydrase (CA) with a 99mTc-labeled small molecule inhibitor (2011) (0)
- Development of Radiochemically Pure Antibodies 1 (2006) (0)
- The use of animal models in the development of radiopharmaceuticals (1989) (0)
- In vitro and in vivo properties of (/sup 125/I) (R,S) 4IQNB: A lower affinity diastereomeric muscarinic receptor radiotracer (1985) (0)
- Radiopharmaceuticals for tomographic imaging of the brain. (1988) (0)
- Small molecule PSMA inhibitors for targeted molecular imaging of prostate cancer (2008) (0)
- Changes over the years in radiopharmaceutical design. (2019) (0)
- Targeted Molecular Imaging (2012) (0)
- RADIOCHEMISTRY AND RADIOPHARMACEUT1CALS RadioiodinatedEstrogenDerivatives (2006) (0)
- Evaluation of [76Br]BMK-152 non-peptide analogues for corticotropin-releasing hormone type 1 receptor (CRHR1) (2006) (0)
- Nuclear Imaging and Biomarkers in Drug Development Using Approved Radiopharmaceuticals (2001) (0)
- Nuclear medicine pioneer Katherine Austin Lathrop, 1915-2005 (2005) (0)
- The effect of chemical modification on the immunologic activity of Fab 96. 5 (1985) (0)
- Michael J. Welch PhD, 1939-2012 (2012) (0)
- Modern Imaging Technology: Recent Advances (2004) (0)
- Further information on the aims and scope of nuclear medicine and biology (2012) (0)
- Comparison of the brain pharmacokinetics (PK) of different derivatives of 11C-labeled TZTP for imaging muscarinic M2 receptors (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William C. Eckelman?
William C. Eckelman is affiliated with the following schools: